-
Business
-
Policy & Business
-
-
Federal IT
-
Information Technology
-
-
State & Local
-
State & Local Government
-
-
Defense
-
Defense & Intelligence
-
-
Healthcare
-
Healthcare Policy & IT
-
-
Energy
-
Energy Policy & Technology
-
-
Education
-
Education Policy & Technology
-
Sleep Aid Must Carry Warning About Drowsiness, FDA Says
NBC News: Lunesta, a popular prescription sleep aid, must change its label to warn users that they may still be too drowsy to drive safely and perform other activities after taking it, the Food and Drug Administration says.
The drug must also lower the recommended starting dose, the FDA said.
Tags
Share
Top Stories
- CMS watchdog suggests targeted approach for hospital wage index increase
- When PHE Ends, Don't Expect Grace Period From CMS
- Lawmakers left hospital, insurer contract guardrails out of year-end proposal
- CMS creates direct contracting model to serve individuals dually eligible for Medicare and Medicaid
- Local Health Departments Are Understaffed. Would Biden’s ‘Public Health Jobs Corps’ Help?
- HHS wants to boost interoperability for Medicaid and CHIP
- CDC is giving $227 million for COVID-19 vaccine preparedness and tracking
- ‘We want them infected’: Trump appointee demanded ‘herd immunity’ strategy, emails reveal
- CMS Updates Part B Payment Information for COVID-19 Treatments
- FDA finds Moderna vaccine 95% effective
- FDA Analysis Of Pfizer COVID-19 Vaccine Finds It Effective And Safe
- High court will hear appeal over Medicaid work requirements
- Bipartisan Cadre of Lawmakers Call for Permanent Telehealth Expansion
- Biden Will Issue Mask Mandate for Federal Buildings
- CMS unveils highly anticipated geographic direct-contracting model
- Pushed to rush, FDA head says feds will get vaccine 'right'
Whitepapers & Special Reports
i360Gov Newsletters
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe NowAlso in Healthcare Policy & IT
About
i360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Contact Us
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
Newsletters
Copyright © 2009-2025 i360Communications, LLC.